Hypertensive nephropathy: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
 
No edit summary
 
(18 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{{DiseaseDisorder infobox |
  Name        = Hypertensive nephropathy |
  ICD10      = {{ICD10|I|12||i|10}} |
  ICD9        = {{ICD9|403}} |
}}
{{SI}}
{{CMG}}
__NOTOC__
__NOTOC__
{{Hypertensive nephropathy}}
'''For patient information, click [[Hypertensive nephropathy (patient information)|here]]'''


{{CMG}} {{AE}} {{AN}}{{NN}}


'''Hypertensive nephropathy''' (or "hypertensive nephrosclerosis", or "Hypertensive renal disease") is a medical condition referring to damage to the [[kidney]] due to chronic [[high blood pressure]].
{{SK}} Hypertensive nephrosclerosis; hypertensive renal disease


It should be distinguished from "[[renovascular hypertension]]" (I15.0), which is a form of [[secondary hypertension]].
==[[Hypertensive nephropathy overview|Overview]]==


In the kidneys, as a result of ''benign [[arterial hypertension]]'', [[hyaline]] (pink, amorphous, homogeneous material) accumulates in the wall of small arteries and arterioles, producing the thickening of their walls and the narrowing of the [[Lumen (anatomy)|lumen]]s — hyaline [[arteriolosclerosis]]. Consequent [[ischemia]] will produce [[tubular atrophy]], [[interstitial fibrosis]], glomerular alterations (smaller [[glomeruli]] with different degrees of hyalinization - from mild to sclerosis of glomeruli) and periglomerular fibrosis. In advanced stages, [[renal failure]] will occur. Functional nephrons have dilated tubules, often with hyaline [[casts]] in the lumens.
==[[Hypertensive nephropathy classification|Classification]]==


==See also==
==[[Hypertensive nephropathy pathophysiology|Pathophysiology]]==
 
==[[Hypertensive nephropathy differential diagnosis|Differentiating Hypertensive Nephropathy from other Diseases]]==
 
==[[Hypertensive nephropathy epidemiology and demographics|Epidemiology and Demographics]]==
 
==[[Hypertensive nephropathy risk factors|Risk Factors]]==
 
==[[Hypertensive nephropathy screening|Screening]]==
 
==[[Hypertensive nephropathy natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
 
==Diagnosis==
 
[[Hypertensive nephropathy history and symptoms|History and Symptoms ]] | [[ Hypertensive nephropathy physical examination|Physical Examination]] | [[Hypertensive nephropathy laboratory findings|Laboratory Findings]] | [[Hypertensive nephropathy electrocardiogram|Electrocardiogram]] | [[Hypertensive nephropathy abdominal x ray|Abdominal X Ray]] | [[Hypertensive nephropathy CT|CT]] | [[Hypertensive nephropathy ultrasound|Ultrasound]] | [[Hypertensive nephropathy other imaging findings|Other Imaging Findings]] | [[Hypertensive nephropathy other diagnostic studies|Other Diagnostic Studies]]
 
==Treatment==
[[Hypertensive nephropathy medical therapy|Medical Therapy]] | [[Hypertensive nephropathy primary prevention|Primary Prevention]] | [[Hypertensive nephropathy secondary prevention|Secondary Prevention]] | [[Hypertensive nephropathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[Hypertensive nephropathy future or investigational therapies|Future or Investigational Therapies]]
 
==Case Studies==
 
[[Hypertensive nephropathy case study one|Case #1]]
 
==Related Chapters==
* [[Nephropathy]]
* [[Nephropathy]]


==External links==
*[http://www.pathologyatlas.ro/Nephroangiosclerosis.html Photo at Atlas of Pathology]
*{{cite journal |author=Tylicki L, Rutkowski B |title=[Hypertensive nephropathy: pathogenesis, diagnosis and treatment] |language=Polish |journal=Pol. Merkur. Lekarski |volume=14 |issue=80 |pages=168-73 |year=2003 |pmid=12728683 |doi=}}
*[http://ndt.oxfordjournals.org/cgi/content/full/15/10/1515 Oxford Journals]


{{Circulatory system pathology}}
{{Circulatory system pathology}}


 
[[Category:Disease]]
[[Category:Emergency medicine]]
[[Category:Kidney diseases]]
[[Category:Kidney diseases]]
[[Category:Cardiology]]
[[Category:Nephrology]]


[[de:Nephrosklerose]]
[[de:Nephrosklerose]]

Latest revision as of 10:08, 31 May 2020

Hypertensive nephropathy Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Differentiating Hypertensive Nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Abdominal X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypertensive nephropathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypertensive nephropathy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertensive nephropathy

CDC on Hypertensive nephropathy

Hypertensive nephropathy in the news

Blogs on Hypertensive nephropathy

Directions to Hospitals Treating Hypertensive nephropathy

Risk calculators and risk factors for Hypertensive nephropathy

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]Nasrin Nikravangolsefid, MD-MPH [3]

Synonyms and keywords: Hypertensive nephrosclerosis; hypertensive renal disease

Overview

Classification

Pathophysiology

Differentiating Hypertensive Nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Abdominal X Ray | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters


de:Nephrosklerose

Template:WH Template:WikiDoc Sources